Chemotherapy and Radiation
710 articles
The American Association for Cancer Research (AACR) Virtual Special Conference: Pancreatic Cancer Day Two
Let’s Win and the Lustgarten Foundation bring you the highlights from Day Two of the AACR special conference on pancreatic cancer.
Vigilance Leads to Pancreatic Cancer Diagnosis
After his pancreatic cancer diagnosis, Michael Whalen searched for someone willing to treat him with chemotherapy.
Gathering Information for the Right Treatment
Staci and Rich Grodin applied their medical information research skills when Rich was diagnosed with pancreatic cancer.
My Pancreatic Cancer Clinical Trial Journey
After starting pancreatic cancer treatment, Davi D’Agostino discovered she has the BRCA2 mutation, which made her eligible for a clinical trial.
Summer Safety for Pancreatic Cancer Patients
In the heat of the summer, pancreatic cancer patients face summer safety challenges so they don’t overheat, burn, or exhaust themselves.
Finding Humor During Cancer Treatment
Comedian John Ziegler has managed to find the humor in the diagnosis and treatment of pancreatic cancer.
New Study to Get More Minorities Involved in Genetic Testing
Dr. Nicolette Rodriguez leads the REGENERATE study to find the best ways to get more Black and Latinx Americans genetic testing for cancer.
Medical Marijuana: More Science Could Help Clear the Air
What’s the scoop on medical marijuana? Legal? Helpful? Find the most up-to-date information on what it is approved for, and where the research is going.
Genetic Testing Can Help Those You Love
Dr. Fay Kastrinos, director of the Muzzi Mirza Pancreatic Cancer Prevention and Genetics Program at Columbia University Medical Center, explains the value of genetic testing for cancer prevention and treatment.
Targeting Metabolic Vulnerability
Dr. Jordan Winter looks at cell metabolism to find areas of vulnerability in pancreatic cancer cells, to find a way to create better treatments.
Looking Back at the Year in Research: 2019
Research highlights of 2019 include: approval of a PARP inhibitor, artificial intelligence to diagnose pancreatic cysts, and updated radiation guidelines.
New Study Aims to Reduce Recurrence Risk for Select Patients
Dr. Kim A. Reiss is leading a study of the PARP inhibitor olaparib to delay or prevent a recurrence of surgically removed pancreatic cancer.
Radiation and Chemotherapy to Make Pancreatic Cancer Surgically Removable
Can a combination of radiation and chemotherapy make pancreatic tumors that are borderline removeable better candidates for surgery? A clinical trial looks at this question.
Important Questions When Starting Pancreatic Cancer Treatment
Dr. Gauri Varadhachary outlines the important questions to ask when you start treatment with surgery, chemotherapy, or radiation for pancreatic cancer.
COVID-19: What You Should Do Now
Learn what you should do to prevent the spread of COVID-19, especially if you have a weakened immune system from pancreatic cancer treatment.